What one share of Viking Therapeutics holds
We are a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.
Viking Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$4.67 |
| Cash and investments | $1.08 |
| Book value | $3.50 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | $0.00 | −$5.23 | — | — | — | −$3.69 |
| 2015 | $0.00 | −$3.68 | — | — | — | $0.90 |
| 2016 | $0.00 | −$0.91 | — | — | — | $0.39 |
| 2017 | $0.00 | −$0.79 | — | — | — | $0.38 |
| 2018 | $0.00 | −$0.38 | — | — | — | $4.15 |
| 2019 | $0.00 | −$0.36 | — | — | — | $3.83 |
| 2020 | $0.00 | −$0.54 | — | — | — | $3.34 |
| 2021 | $0.00 | −$0.71 | — | — | — | $2.58 |
| 2022 | $0.00 | −$0.90 | — | — | — | $1.86 |
| 2023 | $0.00 | −$0.91 | — | — | — | $3.48 |
| 2024 | $0.00 | −$1.01 | — | — | — | $7.89 |
| 2025 | $0.00 | −$3.19 | — | — | — | $5.57 |
Common questions about Viking Therapeutics
How much does one share of Viking Therapeutics earn?
Over the last 12 months, Viking Therapeutics lost $4.67 for each share.
Does Viking Therapeutics pay a dividend?
Viking Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Viking Therapeutics’s book value per share?
Viking Therapeutics’s book value is $3.50 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Viking Therapeutics have?
Each share of Viking Therapeutics has $1.08 of cash and investments, as of June 30, 2026.
Has Viking Therapeutics bought back shares?
Viking Therapeutics’s share count rose about 2591% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.